Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03060538
What this trial is testing

A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver Disease

Who this might be right for
Diabetes Mellitus, Type 2Non-Alcoholic Fatty Liver Disease
Genentech, Inc. 154
Not applicableLooking for participantsNCT07086989
What this trial is testing

Cardiovascular Risk in Children With Chronic Conditions Study

Who this might be right for
Kidney TransplantFamilial HypercholesterolaemiaType 1 Diabetes Mellitus (T1DM)+22 more
Semmelweis University 300
Testing effectiveness (Phase 2)Study completedNCT04618744
What this trial is testing

Assess the Safety and Efficacy of Oral Insulin in T2DM Patients With Nonalcoholic Steatohepatitis (NASH)

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic Steatohepatitis
Oramed, Ltd. 32
Not applicableNot Yet RecruitingNCT07820800
What this trial is testing

NMR Metabolomics-Based Risk Assessment and Stratified Digital Health Interventions in Middle-Aged Adults (PREMAP)

Who this might be right for
Type 2 DiabetesCoronary Heart DiseaseMyocardial Infarction+4 more
University of Eastern Finland 1,400
Not applicableUnknownNCT05513729
What this trial is testing

Effect of Canagliflozin on Liver Inflammation Damage in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver Disease

Who this might be right for
Type 2 Diabetes Mellitus With Complication
First Affiliated Hospital Xi'an Jiaotong University 80
Testing effectiveness (Phase 2)Study completedNCT03371355
What this trial is testing

Study of ISIS 703802 in Participants With Hypertriglyceridemia, Type 2 Diabetes Mellitus, and Nonalcoholic Fatty Liver Disease

Who this might be right for
NAFLDDiabetes Mellitus, Type 2Hypertriglyceridemia+1 more
Akcea Therapeutics 105
Not applicableStudy completedNCT05946148
What this trial is testing

Novel Antidiabetic Medications and Their Effect on Liver Steatosis (NAMELS-18)

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseLiver Steatosis
National and Kapodistrian University of Athens 78
Post-approval studies (Phase 4)Study completedNCT02875821
What this trial is testing

Effects of Ipragliflozin on Excessive Fat in Type 2 Diabetes Patients With Non-alcoholic Fatty Liver Disease Treated With Metformin and Pioglitazone

Who this might be right for
Type 2 Diabetes With Non-alcoholic Fatty Liver (NAFLD)
Yonsei University 44
Post-approval studies (Phase 4)Study completedNCT01002547
What this trial is testing

Prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) in Hispanics With Diabetes Mellitus Type 2 (T2DM) and Role of Treatment

Who this might be right for
Nonalcoholic Steatohepatitis
VA Office of Research and Development 105
Testing effectiveness (Phase 2)WithdrawnNCT03291249
What this trial is testing

Assessment of the Safety of Foralumab, an Oral Anti-CD3 Antibody, in Patients With NASH and T2DM

Who this might be right for
NASH - Nonalcoholic SteatohepatitisNAFLDT2DM (Type 2 Diabetes Mellitus)
Tiziana Life Sciences LTD
Testing effectiveness (Phase 2)UnknownNCT04702490
What this trial is testing

Study to Evaluate MET409 Alone or in Combination With Empagliflozin in Patients With Type 2 Diabetes and NASH

Who this might be right for
NASHNASH - Nonalcoholic SteatohepatitisType 2 Diabetes+5 more
Metacrine, Inc. 120
Testing effectiveness (Phase 2)Study completedNCT03205150
What this trial is testing

Effect of LIK066 on Reduction of Fatty Content in Livers of Obese Patients

Who this might be right for
Obese Patients With Non-alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 107
Testing effectiveness (Phase 2)Active Not RecruitingNCT05464784
What this trial is testing

MN-001 in Non-alcoholic Fatty Liver Disease, Type 2 Diabetes Mellitus, and Hypertriglyceridemia

Who this might be right for
Diabetes Mellitus, Type 2HypertriglyceridemiaNon-Alcoholic Fatty Liver Disease
MediciNova 40
Post-approval studies (Phase 4)Study completedNCT03068065
What this trial is testing

Antidiabetic Effects on Intrahepatic Fat

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseType2 Diabetes
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 87
Not applicableEnded earlyNCT01260246
What this trial is testing

Sitagliptin for the Treatment of Non-alcoholic Steatohepatitis in Patients With Type 2 Diabetes

Who this might be right for
Type 2 DiabetesNonalcoholic Steatohepatitis
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 12
Post-approval studies (Phase 4)UnknownNCT04976283
What this trial is testing

Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver

Who this might be right for
Diabetes Mellitus, Type 2NASH - Nonalcoholic SteatohepatitisNAFLD
Getz Pharma 123
Large-scale testing (Phase 3)UnknownNCT03970031
What this trial is testing

MSDC-0602K to Assess Glycemic Control and Cardiovascular Outcomes in Patients With Pre-T2D or T2D and NAFLD/NASH

Who this might be right for
Type2 DiabetesNASH - Nonalcoholic SteatohepatitisNonalcoholic Steatohepatitis+1 more
Cirius Therapeutics, Inc. 1,800
Early research (Phase 1)Looking for participantsNCT06694935
What this trial is testing

A Phase 1b Study of QX1206 in T2DM Patients With NAFLD

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Non-Alcoholic Fatty Liver Disease (NAFLD)
1Globe Health Institute 52
Not applicableStudy completedNCT03165877
What this trial is testing

Effect of Low-glycemic Index Meals Intake on DM2 Women Under Metformin Therapy

Who this might be right for
Diabetes Mellitus, Type 2
Universidad de Valparaiso 13
Not applicableStudy completedNCT04241575
What this trial is testing

Identification of Fatty Liver With Advanced Fibrosis in Type 2 Diabetes Using Simple Fibrosis Scores and Electronic Reminder Messages

Who this might be right for
Fatty Liver, NonalcoholicDiabetes Mellitus, Type 2
Chinese University of Hong Kong 1,061
Next Page